Related Experiment Video
Updated: Mar 11, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Strategy for the hemocompatibility testing of microparticles
S Braune1, S Basu1,2, K Kratz1
1Institute of Biomaterial Science and Berlin-Brandenburg Centre for Regenerative Therapies (BCRT), Helmholtz-Zentrum Geesthacht, Teltow, Germany.
A new in vitro dynamic whole blood test system accurately assesses the hemocompatibility of polymer microparticles. This system reveals differences in blood cell interactions and activation, crucial for medical device development.
Area of Science:
- Biomaterials Science
- Hemocompatibility Testing
- Polymer Microparticles
Background:
- Polymer microparticles are used in medical devices, requiring rigorous hemocompatibility evaluation.
- Existing in vitro assays for hemocompatibility are often non-standardized and lack dynamic whole blood analysis.
- Regulatory agencies mandate thorough in vitro testing to prevent adverse events like thrombosis and inflammation.
Purpose of the Study:
- To develop and validate a standardized in vitro dynamic whole blood test system for assessing polymer microparticle hemocompatibility.
- To evaluate the hemocompatibility of poly(ether imide) (PEI) microparticles with varying surface properties.
- To analyze microparticle interactions with whole blood, including thrombus formation, cell counts, and platelet activation.
Main Methods:
- Utilized a novel syringe-based dynamic test system with fresh human whole blood under standardized conditions.
- Incorporated sterilized poly(ether imide) (PEI) microparticles (140±30 μm) with nanoporous surfaces and varying wettabilities.
- Analyzed thrombi formation, circulating blood cell counts, platelet activation (P-Selectin), platelet function (PFA100), thrombin formation, and hemolysis (free hemoglobin).
Main Results:
- Microscopic evaluation showed thrombi formation and particle aggregation with all tested microparticles.
- Significant reductions in circulating platelets and monocytes (up to 50%) were observed compared to controls.
- Elevated platelet activation, thrombin levels, and hemolysis indicated clear differentiation between particle types and validated the test system's sensitivity.
Conclusions:
- The developed in vitro dynamic whole blood test system provides sensitive and validated hemocompatibility analysis for polymer microparticles.
- The system effectively differentiates between microparticle types based on their interactions with whole blood components.
- This test system enables comprehensive evaluation of cell-material interactions and platelet function, crucial for biomaterial development in medical devices.
More Related Videos
06:56Isolation and Characterization of Neutrophil-derived Microparticles for Functional Studies
Published on: March 2, 2018
09:58Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
Published on: June 23, 2022